Recombinant Nocardia farcinica ATP synthase subunit b (atpF) is a protein produced using recombinant DNA technology, with the gene originating from the bacterium Nocardia farcinica . ATP synthase, or F-ATPase, is a vital enzyme that produces adenosine triphosphate (ATP), the primary energy currency of cells . Subunit b is a component of the F0 sector of the ATP synthase complex .
ATP synthase is essential for energy production in living organisms . It catalyzes the synthesis of ATP from adenosine diphosphate (ADP) and inorganic phosphate, utilizing the electrochemical gradient of protons across a membrane . The F0 sector of ATP synthase is embedded in the membrane and facilitates proton translocation, while the F1 sector is responsible for ATP synthesis . Subunit b is a crucial component of the F0 sector, playing a role in the structural integrity and function of the enzyme complex .
ELISA: Recombinant Nocardia farcinica ATP synthase subunit b (atpF) can be used in Enzyme-Linked Immunosorbent Assays (ELISA) .
Research: This recombinant protein is valuable in studying ATP synthase structure, function, and its role in bacterial metabolism . It can also be used to investigate potential therapeutic targets for Nocardia infections .
Nocardia farcinica is an aerobic, Gram-positive bacterium known to cause a range of infections, particularly in immunocompromised individuals . It is one of the most pathogenic species within the Nocardia genus, capable of causing pulmonary, disseminated, and cutaneous infections .
Virulence factors associated with N. farcinica contribute to its pathogenicity:
Nfa34810: Nocardia farcinica protein Nfa34810 is an immunodominant protein that facilitates the invasion of host cells . Nfa34810 promotes the production of TNF-α in macrophages, depending on the activation of ERK, JNK, and NF-κB signaling pathways via TLR4 .
Cholesterol Oxidase (ChoD): ChoD from N. erythropolis can activate p38 mitogen-activated kinase and stimulate the production of IL-10 via Toll-like receptor 2 (TLR2) .
Pathogen-Associated Molecular Patterns (PAMPs): The activation of TLRs by PAMPs can lead to the activation of MAPK and NF-κB signaling pathways, which is crucial for the modulation of innate immunity .
Effect of β-hydroxy-γ-aminophosphonate (β-HPC): Research indicates that β-HPC increases the metabolic activity of N. brasiliensis, enhancing growth and the hydrolysis of substrates such as casein, L-tyrosine, egg yolk, and tween 80 .
Genome Sequencing: Complete genome sequence analysis of Nocardia brasiliensis provides insights into its genetic composition and potential virulence factors .
Recombinant Nocardia farcinica ATP synthase subunit b (atpF) is available from various suppliers, including:
KEGG: nfa:NFA_10610
STRING: 247156.nfa10610
ATP synthase subunit b (atpF) is a critical component of the F0F1 ATP synthase complex in Nocardia farcinica, an opportunistic pathogen that causes nocardiosis in humans and animals. The ATP synthase complex catalyzes the formation of ATP from ADP and inorganic phosphate, serving as one of the most crucial protein complexes in energy metabolism .
In N. farcinica, this protein consists of 186 amino acids with the sequence: MYEYSVLAAESGEDVNPLIPATYDIVWSVVCVAIIAVVFYKYVIPRLTKVLNERADKIEGGIAKAEAAQAEAQQTLEQYQQQLADARLEAARIREDARTQGQQILAQMRAEAQAESDRIVAAGHAQLEAQRQQILTELRSEVGRTAVDLAEKIIGQSVSDEAKQAASIERFLSELDSSDA GIGVGR .
The atpF gene (designated as NFA_10610 in the N. farcinica IFM 10152 genome) produces a protein that functions as part of the membrane-embedded F0 sector of ATP synthase . This protein's role in energy metabolism makes it particularly interesting when studying this pathogen's survival mechanisms both in environmental and host conditions.
The recombinant expression of N. farcinica atpF has been successfully achieved using the following methodological approach:
Expression System Selection:
E. coli is the predominant expression system for producing recombinant N. farcinica atpF protein . This system offers advantages including rapid growth, high protein yields, and well-established protocols.
Expression Construct Design:
The full-length atpF gene (encoding amino acids 1-186) should be cloned into a suitable expression vector
Addition of purification tags is recommended - typically an N-terminal His-tag or His-SUMO tag
The construct should include appropriate promoters (T7 is commonly used) and selection markers
Optimization Parameters:
Induction conditions: IPTG concentration (typically 0.1-1.0 mM), temperature (often lowered to 16-25°C for membrane proteins), and duration (4-16 hours)
Growth medium: Rich media (like LB) or minimal media depending on downstream applications
Codon optimization may be necessary due to the high G+C content (70.8%) of N. farcinica
For extraction of the protein, careful lysis buffer selection is critical since atpF is a membrane protein component. Buffers containing mild detergents such as n-dodecyl-β-D-maltoside (DDM) or Triton X-100 have proven effective for similar membrane proteins.
Multiple complementary methods should be employed to thoroughly assess both purity and activity:
Purity Assessment Methods:
SDS-PAGE: The purity of recombinant atpF can be determined using SDS-PAGE, with expected purity levels of ≥85-90% . The theoretical molecular weight of atpF is approximately 20.3 kDa .
Western Blot: Using antibodies against the protein itself or the purification tag to confirm identity.
Mass Spectrometry: For definitive identification and purity assessment. As demonstrated in related ATP synthase purification protocols, MS can identify all components and contaminants .
Blue-Native PAGE: Particularly useful if studying the protein as part of the complete ATP synthase complex .
Activity Assessment Methods:
While direct activity assays for isolated atpF are challenging since it functions as part of a complex, these approaches can be valuable:
Reconstitution Experiments: Incorporating purified atpF into liposomes with other ATP synthase components.
ATP Hydrolysis Assay: If studying the complete ATP synthase complex containing atpF, an ATP hydrolysis assay can be conducted as described in related protocols .
Binding Studies: Assessing interaction with other ATP synthase subunits using techniques such as surface plasmon resonance or pull-down assays.
When investigating atpF function, several experimental design approaches can be employed:
One Factor at a Time (OFAT) Approach:
Full Factorial Design:
Fractional Factorial Design:
Response Surface Method (RSM):
Definitive Screening Design (DSD):
Selection of the appropriate design should be based on:
The specific research question
Available resources
Required precision
Number of factors to be investigated
For structure-function studies, site-directed mutagenesis experiments focusing on conserved residues would be particularly valuable.
The ATP synthase subunit b (atpF) in N. farcinica shares structural similarities with homologous proteins in other bacteria, but with some notable distinctions:
Sequence Comparison:
N. farcinica atpF consists of 186 amino acids , which is consistent with atpF proteins from other bacteria in the Actinomycetales family. Homology analysis reveals higher sequence similarity with other mycobacterial species compared to more distant bacterial species.
Structural Features:
A transmembrane domain at the N-terminus embedded in the membrane
A cytoplasmic domain that interacts with the F1 sector
A dimerization interface for forming the b-b subunit dimer
Comparative Table of atpF Proteins Across Selected Bacteria:
| Species | Amino Acid Length | Molecular Weight (kDa) | Notable Structural Features |
|---|---|---|---|
| Nocardia farcinica | 186 | 20.3 | High hydrophobicity in N-terminal region |
| Mycobacterium tuberculosis | 168 | 18.4 | Similar structural organization |
| Synechocystis sp. PCC 6803 | 177 | 19.2 | More divergent sequence but conserved function |
| E. coli | 156 | 17.3 | Contains more charged residues |
Understanding these structural relationships is important for:
Interpreting experimental results
Designing structure-based drug targeting strategies
Predicting functional conservation or divergence
Comparative analysis of atpF across species can provide insights into the evolution of ATP synthase and adaptation mechanisms in different bacterial environments.
While atpF itself has not been directly implicated in drug resistance mechanisms of N. farcinica based on the provided search results, several hypotheses can be formulated based on the broader context of ATP synthase involvement in bacterial physiology:
Potential Mechanisms:
Energy-Dependent Efflux Systems:
ATP synthase generates ATP that powers membrane efflux pumps, which can expel antibiotics from bacterial cells. Altered ATP synthase function could impact the energy availability for these systems .
Metabolic Adaptation:
N. farcinica has demonstrated versatile metabolic capabilities, including diverse metabolic pathway genes and numerous oxygenases . ATP synthase function may be critical for energy provision during metabolic adaptations that confer resistance.
Membrane Integrity:
As part of the membrane-embedded F0 complex, atpF might influence membrane properties that affect antibiotic penetration.
Research Context:
N. farcinica has demonstrated resistance to multiple antibiotics, including:
Rifampin (through an unusual mechanism involving duplicate copies of rpoB genes)
Some strains have shown resistance to trimethoprim-sulfamethoxazole
While ATP synthase is not a direct target of these antibiotics, its role in energy metabolism makes it a potential indirect factor in resistance mechanisms, particularly those requiring energy-dependent processes.
Experimental approaches to investigate this relationship could include:
Controlled expression studies of atpF and correlation with antibiotic susceptibility
ATP synthesis measurement in resistant versus susceptible strains
Membrane potential analysis in the context of antibiotic exposure
Site-directed mutagenesis of atpF represents a powerful approach for dissecting the structure-function relationships of this protein:
Key Residues for Mutagenesis:
Transmembrane Domain Residues:
Interface Residues:
Conserved Motifs:
Residues conserved across bacterial species are prime candidates for functional importance
The C-terminal region often contains residues critical for F1 sector interaction
Methodological Approach:
Design of Mutations:
Alanine scanning: Systematically replacing residues with alanine
Conservative vs. non-conservative substitutions
Deletion or insertion mutations in non-critical structural regions
Expression Systems:
Functional Assays:
ATP synthesis/hydrolysis measurements
Proton translocation assays
Binding studies with other subunits
Structural integrity assessment via circular dichroism or thermal stability assays
Analysis Framework:
Comparison to wild-type protein
Correlation of structural changes with functional impacts
Molecular modeling to interpret results
This systematic approach can reveal:
Essential residues for catalytic function
Structural elements required for proper assembly
Regions involved in subunit interactions
Potential sites for therapeutic targeting
Investigating the interactions between atpF and other ATP synthase subunits requires a multifaceted approach:
Co-purification Methodologies:
FLAG-Tag Affinity Purification:
The use of FLAG-tagged proteins has proven effective for isolating intact ATP synthase complexes. A protocol using 3×FLAG tag fused to the beta subunit demonstrates this approach for obtaining enzymatically active complexes .
Key steps:
Express FLAG-tagged atpF in appropriate system
Cell lysis under non-denaturing conditions
Capture on anti-FLAG resin
Gentle elution using 3×FLAG peptide
Analysis of co-purified proteins
Co-immunoprecipitation:
As noted in search result , "For co-immunoprecipitation assays, both 0.1 M glycine HCl (pH 3.5) or SDS-PAGE sample buffer can be considered for elution instead of the 3×FLAG peptide used here; in that case the eluted samples can proceed directly to SDS-PAGE, followed by mass spectrometry to identify protein components."
Interaction Analysis Techniques:
Blue-Native PAGE:
This technique maintains protein-protein interactions and can visualize intact ATP synthase complexes containing atpF .
Crosslinking Mass Spectrometry:
Chemical crosslinkers can capture transient interactions, followed by MS analysis to identify specific interaction sites between atpF and other subunits.
Surface Plasmon Resonance (SPR):
For quantitative measurement of binding kinetics between atpF and individual partner subunits.
Förster Resonance Energy Transfer (FRET):
When studying dynamics of interactions in real-time.
Advanced Structural Methods:
Cryo-Electron Microscopy:
For visualizing the complete ATP synthase structure and determining the exact positioning of atpF within the complex.
X-ray Crystallography:
If crystallization of subcomplexes containing atpF is achievable.
Functional Validation:
Reconstitution Experiments:
Combining purified components including atpF to restore ATP synthesis activity in liposomes or nanodiscs.
Mutagenesis of Interface Residues:
Strategic mutations at predicted interaction sites can validate their importance through disruption of binding or assembly.
Recombinant atpF protein from N. farcinica has potential applications in diagnostic tools for Nocardia infections:
Antibody-Based Diagnostics:
Antigen Production:
Purified recombinant atpF can serve as an antigen for generating highly specific polyclonal or monoclonal antibodies against N. farcinica.
Immunoassay Development:
ELISA-based detection systems using anti-atpF antibodies
Lateral flow assays for point-of-care diagnostics
Immunohistochemistry for tissue samples
PCR-Based Diagnostics:
Species-Specific Detection:
Similar to the approach used for N. farcinica identification through the 314-bp PCR fragment described in search result , atpF gene sequences could serve as targets for species-specific PCR-based diagnostics.
The search results describe: "PCR amplification of genomic DNA from 28 N. farcinica isolates with Nf1 and Nf2 generated a single intense 314-bp fragment. The specificity of the assay with these primers was verified, since there were no PCR amplification products observed from heterologous nocardial species (n = 59) or other related bacterial genera (n = 41)."
Design Considerations:
Primers targeting unique regions of the atpF gene
Optimization of PCR conditions for clinical samples
Validation against related Nocardia species
Metagenomic Approaches:
Next-Generation Sequencing:
The search results mention successful identification of N. farcinica infection using metagenomic next-generation sequencing (mNGS) . Similar approaches could incorporate atpF sequences as markers.
Practical Implementation:
When developing such diagnostic applications, researchers should consider:
Sensitivity and specificity requirements for clinical use
Sample preparation methods from various clinical specimens
Validation against gold standard methods
Integration with existing diagnostic workflows
Early and accurate diagnosis of N. farcinica infections is particularly important due to the organism's resistance to multiple antibiotics and the need for specific treatment approaches .
Investigating the role of atpF in N. farcinica pathogenesis requires a comprehensive experimental strategy:
Genetic Manipulation Approaches:
Gene Knockout/Knockdown:
CRISPR-Cas9 systems adapted for Nocardia
Antisense RNA strategies
Construction of conditional mutants if atpF is essential
Complementation Studies:
Re-introduction of wild-type or mutant atpF to confirm phenotypes
Expression under native or inducible promoters
Infection Models:
In Vitro Cellular Models:
Macrophage infection assays to assess intracellular survival
Epithelial cell adhesion and invasion studies
Co-culture systems mimicking host environments
Animal Models:
Mouse models of pulmonary or disseminated nocardiosis
Assessment of bacterial burden, histopathology, and immune response
Comparison of wild-type and atpF-modified strains
Molecular Pathogenesis Studies:
Transcriptomic Analysis:
RNA-seq to identify genes co-regulated with atpF during infection
Comparison of expression patterns between environmental and host conditions
Metabolic Profiling:
Assessment of energy metabolism in wild-type vs. atpF-modified strains
Analysis of metabolic adaptation to host environments
Protein-Protein Interaction Studies:
Identification of host proteins that might interact with ATP synthase components
Investigation of potential moonlighting functions of atpF beyond energy metabolism
Clinical Correlation:
Analysis of Clinical Isolates:
Sequencing of atpF in clinical isolates with varying virulence
Correlation of atpF sequence variants with disease severity or presentation
The search results highlight N. farcinica's ability to cause severe infections, including pneumonia, central nervous system involvement, and cutaneous tissues . Understanding atpF's role in the pathogen's energy metabolism during infection could provide insights into its adaptation to different host environments and potential vulnerabilities for therapeutic targeting.
Purification of functional atpF presents several challenges due to its nature as a membrane protein component of a larger complex:
Key Challenges and Solutions:
Membrane Protein Solubilization:
Challenge: atpF contains hydrophobic transmembrane domains that make it difficult to solubilize while maintaining native structure.
Solutions:
Use mild detergents (DDM, LMNG, or digitonin) to preserve protein integrity
Implement detergent screening to identify optimal conditions
Consider amphipols or nanodiscs for stabilization after purification
Maintaining Functional State:
Challenge: Isolated atpF may lose functional capacity when separated from the ATP synthase complex.
Solutions:
Expression Levels:
Challenge: Membrane proteins often express poorly in heterologous systems.
Solutions:
Optimize codon usage for the expression host
Test different promoter strengths and induction conditions
Use specialized E. coli strains (C41, C43) designed for membrane protein expression
Consider fusion partners that enhance expression (SUMO, MBP)
Protein Purity Assessment:
Challenge: Contaminating proteins may co-purify with atpF.
Solutions:
Practical Protocol Adaptations:
Based on successful ATP synthase purification methods , the following specific recommendations can be made:
Buffer composition: Include phospholipids to stabilize the membrane protein
Purification approach: Consider FLAG-tagged constructs for gentle, high-affinity purification
Storage conditions: Store in buffer containing 50% glycerol at -20°C for extended stability
Quality control: Assess both purity (≥85-90%) and functional state before experimental use
ATP synthase in N. farcinica shares fundamental structural and functional principles with other bacteria, but with important distinctions that may relate to its pathogenic lifestyle:
Structural Comparison:
Functional Considerations:
Energy Metabolism Adaptation:
N. farcinica possesses extensive metabolic capabilities evidenced by its large genome (6.02 Mb) and numerous oxygenases. Its ATP synthase may be adapted to function under the diverse metabolic conditions encountered during environmental survival and host infection.
Drug Targeting Potential:
While ATP synthase has emerged as a drug target in Mycobacteria (e.g., bedaquiline targeting the c subunit), the specific vulnerability of N. farcinica ATP synthase remains unexplored. The search results indicate that N. farcinica possesses various resistance mechanisms, including to rifampin , suggesting it may have evolved unique features in essential complexes like ATP synthase.
Regulatory Mechanisms:
The regulation of ATP synthase expression and activity in N. farcinica likely reflects its ability to adapt to different environmental conditions, including the host environment during infection.
Research Implications:
Understanding these comparisons can inform:
Potential drug development strategies targeting N. farcinica ATP synthase
Evolutionary adaptations of ATP synthase in actinobacterial pathogens
Mechanisms of metabolic adaptation during the infection process
The search results highlight N. farcinica's versatility and adaptability , which likely extends to the function of its essential energy-generating machinery including ATP synthase and its atpF component.
Several RNA-based methodologies can be employed to investigate the expression patterns and regulatory mechanisms of atpF in N. farcinica:
Quantitative Expression Analysis:
RT-qPCR:
RNA-Seq:
Provides genome-wide transcriptional context for atpF expression
Reveals co-regulated genes and potential operonic structure
Can identify antisense transcripts or other regulatory RNAs affecting atpF
Useful for comparing expression profiles between environmental and host conditions
Regulatory Mechanism Investigation:
5' RACE (Rapid Amplification of cDNA Ends):
Identifies transcription start sites and potential promoter regions
Reveals the presence of untranslated regions that may contain regulatory elements
Reporter Gene Fusions:
Construct fusions of atpF promoter region with reporter genes (GFP, luciferase)
Test promoter activity under different conditions
Identify regulatory elements through deletion analysis
RNA Stability Assays:
Use transcription inhibitors (e.g., rifampicin) followed by time-course sampling
Measure atpF mRNA decay rates under different conditions
Connect to post-transcriptional regulatory mechanisms
Advanced Approaches:
Ribosome Profiling:
Provides insight into translational efficiency of atpF
Identifies potential translational regulation mechanisms
RNA Structure Probing:
Investigates secondary structures in atpF mRNA that may affect expression
Methods include SHAPE (Selective 2'-hydroxyl acylation analyzed by primer extension) and DMS probing
RNA Immunoprecipitation:
Identifies RNA-binding proteins that may regulate atpF expression
Can reveal post-transcriptional regulatory mechanisms
Contextual Considerations:
The search results indicate that N. farcinica has a complex genome with numerous metabolic and resistance genes . The atpF gene likely functions as part of an operon encoding multiple ATP synthase subunits, similar to other bacteria. Understanding its expression patterns may provide insights into the energy metabolism adaptation of this pathogen during infection and environmental survival.
Structure-function studies of recombinant atpF require careful experimental design to generate meaningful insights:
Structural Analysis Approaches:
X-ray Crystallography:
Challenging for membrane proteins but could be attempted with:
Detergent-solubilized protein
Lipidic cubic phase crystallization
Co-crystallization with antibody fragments
Cryo-Electron Microscopy:
Increasingly powerful for membrane proteins
Can visualize atpF in the context of the entire ATP synthase complex
Provides insights into structural arrangements and interactions
NMR Spectroscopy:
Suitable for specific domains or peptide fragments of atpF
Can provide dynamic information not available from static methods
Functional Correlation Designs:
Systematic Mutagenesis:
The following design approaches can maximize information yield:
Domain Swapping Experiments:
Replace domains of atpF with homologous regions from related bacteria
Test chimeric proteins for function to identify species-specific features
Cross-linking Studies:
Use chemical or photo-crosslinkers to capture interaction interfaces
Identify crosslinked products by mass spectrometry
Biophysical Analysis:
Circular Dichroism:
Assess secondary structure content and stability
Monitor structural changes under different conditions
Thermal Shift Assays:
Measure protein stability
Identify conditions or ligands that stabilize the protein
Hydrogen-Deuterium Exchange Mass Spectrometry:
Map solvent-accessible regions
Identify structural dynamics and binding interfaces
Integration with Computational Methods:
Molecular Dynamics Simulations:
Model atpF behavior in membrane environments
Predict effects of mutations on structure and dynamics
Homology Modeling:
Generate structural models based on related proteins
Guide experimental design for validation
For optimal results, a mixed-methods approach combining multiple techniques should be employed. The definitive screening design (DSD) approach mentioned in search result can be particularly valuable for efficiently exploring multiple factors with minimal experimental runs.
Proteomics offers powerful tools for studying atpF in the broader context of N. farcinica physiology:
Interactome Analysis:
Affinity Purification-Mass Spectrometry (AP-MS):
Express tagged atpF in N. farcinica
Purify under native conditions to maintain protein-protein interactions
Identify co-purifying proteins by mass spectrometry
Filter against appropriate controls to identify specific interactors
Proximity Labeling:
Fuse atpF to enzymes like BioID or APEX2
These enzymes biotinylate proteins in close proximity
Identify labeled proteins through streptavidin purification and MS
Particularly valuable for capturing transient interactions
Chemical Cross-linking MS (XL-MS):
Use chemical cross-linkers to stabilize protein-protein interactions
Digest and identify cross-linked peptides by MS
Provides spatial constraints for modeling interaction interfaces
Quantitative Proteomics:
Differential Expression Analysis:
Compare protein abundance in wild-type vs. atpF-modified strains
Identify proteins whose levels change in response to ATP synthase perturbation
Methods include SILAC, TMT, or label-free quantification
Pulse-Chase Proteomics:
Study protein turnover rates using stable isotope labeling
Determine if atpF perturbation affects protein synthesis or degradation rates
Structural Proteomics:
Limited Proteolysis:
Probe structural features of atpF through controlled digestion
Compare accessibility patterns between different conditions
Identify protected regions indicating binding interfaces
Hydrogen-Deuterium Exchange MS:
Map solvent accessibility of atpF regions
Compare exchange patterns in different functional states
Identify regions involved in protein-protein interactions
Systems-Level Analysis:
Protein Correlation Profiling:
Fractionate cellular components (e.g., by centrifugation or chromatography)
Identify proteins with similar distribution profiles to atpF
Infer functional associations based on co-localization
Multi-omics Integration: